Journal of Digestive Diseases and Hepatology

Case Report of Chronic Pancreatitis in aPatient with Celiac Disease and Extra-Intestinal Manifestations of Celiac Disease: Report of a Case and a Literature Review

*Abed Al-Lehibi
Gastroenterology & Endoscopy Department, King Fahad Medical City, King Saud Bin Abdulaziz University-Health Science,Riyadh, Saudi Arabia.
*Corresponding author:Abed Al-Lehibi, Gastroenterology & Endoscopy Department, King Fahad Medical City, King Saud Bin Abdulaziz University-Health Science, Riyadh, Saudi Arabia, Tel: +966-11-288-9999; Email: aha0021@gmail.com;aallehibi@kfmc.med.sa
Received Date: 26 September, 2016; Accepted Date: 12 October, 2016; Published Date: 19 October, 2016

Citation: Enjoji M, Yoshimoto T, Tanaka K, Miyazaki M, Kohjima M et al. (2016) Monocyte-Derived Macrophages Exacerbate Acetaminophen-Induced Liver Injury in Mice through Intrahepatic Hypercoagulation. J Dig Dis Hepatol 2016: 21-26.

Celiac disease is characterized by both inflammation of the small intestine and villous atrophy. It is triggered by exposure to dietary gluten in genetically susceptible individuals. Celiac diseases frequently manifest themselves in a diverse variety of extra intestinal symptoms which are well-documented. There is now evidence of the association of pancreaticobiliary diseases in patients with celiac disease, and it has been reported that celiac disease is associated with an increased risk of pancreatitis and pancreatic insufficiency. In the last 30 years, celiac cases exhibiting extra-intestinal symptoms were not well understood and no clear association with pancreaticobiliary diseases had yet been established. A young female with chronic pancreatitis was referred to our clinic for endoscopic therapy. Her past medical history was of an acute recurrent pancreatitis of a couple of years’ duration, and had been diagnosed with celiac disease.Endoscopic ultrasound revealed severe chronic pancreatitis, with total villous atrophy and flat-shaped duodenal mucosa. The patient was then treated with a combination of gluten-free diet and pancreatic enzymes, with this approach patient showed a dramatic improvement in her symptoms and soon started tolerating the GFD. The patient is free of abdominal pain and has had significant weight gain. In this brief review we reported this and present a literature review.

Celiac disease has been found to occur in genetically susceptible patients, and is closely associated with the genes that code HLA-II antigens, mainly the DQ2 and DQ8 classes. Patients usually present with common gastro-intestinal symptoms, including abdominal pain, diarrhea and weight loss. The disease is common in Europe and the United States, but only sporadic reports of it are found in East Asia, including China.

Celiac disease (CD) has been shown to be associated with a variety of extra-intestinal manifestations involving most organs and systems, and can include pancreatic diseases. A good number of new cases of celiac disease (CD) are diagnosed in adults, and particularly in patients with extra-intestinal symptoms.

Pancreatic abnormalities are uncommon extra-intestinal manifestations of celiac disease. The pancreatic diseases associated with celiac disease are autoimmune pancreatitis, pancreatitis, pancreatitis and pancreatic insufficiency. In a good number of reported cases of pancreatic diseases associated with celiac disease, however, chronic pancreatitis is only reported in a few such cases. Patients with celiac disease with established chronic pancreatitis as an extra-intestinal symptom are often difficult to manage with standard gluten free diet.

Case scenario:

A 15 year old female patient was referred as a case of severe chronic pancreatitis of several years’ duration, with a history of chronic abdominal pain without any history of anorexia to our outpatient clinic of King Fahad Medical City, a tertiary care center in Riyadh, Saudi Arabia. The abdominal pain was diffused, was aggravated by fatty food and not radiating to the back. There was positive history of diarrhea and weight loss. She denied any history of trauma or any offending medications. In addition, there was no family history of acute recurrent or chronic pancreatitis. Over a period of two years she had lost more than 15 kilograms in weight despite having a normal appetite and the use of pancreatic enzymes. With these symptoms she had been managed in a local hospital, where imaging, including a CT scan had been performed, which had revealed chronic calcified pancreatitis. On examination the patient was conscious, with a low body mass index of 16kg/M2. She had stable vitals, her sclera were pale and abdominal examination revealed nothing remarkable. Other systemic examinations were all normal. On evaluation, the patient was shown to have Hemoglobin levels of 8.7gm/dl with low MCV (59) and KCH (16) and high platelet counts of 754.The vitamin D 25-OH was 30 nmol/L. A mild elevation of Amylase level of 150 and lipase level of 94 IgG and IgA and IgM were normal. Tests on renal, liver and blood sugar functions yielded normal results. After initial fluid resuscitation, computed tomography of the abdomen and MRI of the pancreas showed pancreatic atrophy with dilated side branches. Endoscopic ultrasound was then performed, which showed severe chronic pancreatitis based on the Rosemont criteria (hyperechoic foci lobularity, cystic lesions, dilated and irregular main pancreatic duct) but no mass lesion was seen [1]. The patient was taken for endoscopic examination during which duodenal mucosa appeared flat mucosa and scalloping shape. Multiple biopsies were taken and the pathology results showed total villous atrophy and intraepitheliallymphocytosis, with positive serology (AntigliadinIgG II was 124, Antigliadin IgA II was 135, Endomysial IgA was 287 and tissue transglutaminase IgA was 263). The patient was put on a gluten free diet and started on a recommended dose of pancreatic enzymes. With excellent nutritional support, the patient tolerated GFD well. On follow up she had shown a progressive increase in her weight and was symptom-free.

Discussion:

Celiac disease (CD) is commonly encountered in our daily clinical practice. The recognition of the complex clinical picture of the disease and understanding the genetic, environmental, and immunologic components as a background to the pathophysiology of the disease helps the physician to diagnose celiac disease even if the gastrointestinal symptoms are lacking. The increase in incidence implies that a prevalence of 1.0% is possible [2]. A retrospective study of 779 patients with celiac disease observed that the clinical profile of celiac disease has changed over time, with an increased rate of non-classical symptoms, including extra-intestinal manifestations and subclinical indications [3]. The same study reported that the extra-intestinal manifestations included osteopenia/osteoporosis (52%), anemia (34%), cryptogenic hypertransaminasemia (29%) and recurrent miscarriages (12%) [4]. Different neurological symptoms associated with celiac disease including depression, ataxia and encephalopathy associated with celiac disease were also reported [5]. The available data suggest that screening for CD in patients with affective and/or psychiatric symptoms may be useful, since these disorders could be the expression of an organic disease rather than primary psychiatric illnesses [6]. Ghozzi M et al described in their study of 211 patients with articular manifestation that five patients were positive of endomysial antibodies (EmA) (2.37%). Those five patients were respectively showing some gastro-intestinal symptoms and other extra-intestinal manifestations of celiac disease [7]. Liver abnormalities in a patient with celiac disease were also reported, the most frequent of which are primary sclerosing cholangitis (PSC) and primary biliary cirrhosis. [8,9] There are conflicting data supporting dental symptoms in celiac disease, however, the author suggested that CD should be screened for in a patient with systematic dental enamel defects, even in the absence of gastro-intestinal symptoms [10]. However, some of extra- intestinal manifestations are rare, including the pancreatic disorders. It has been demonstrated in a retrospective study of 143,746 patients in the Swedish Patient Register that patients with celiac disease have an almost 3-fold increase in risk of developing pancreatitis, compared with the general population [11,12]. Masoodi I et al reported the first case of auto-immune pancreatitis in a celiac patient [13]. The author suggested that celiac disease should be considered in the etiological work-up of patients with unexplained pancreatitis [14]. The pediatric literature has also reported similar cases [15,16]. In these studies, the index case had a diagnosis of chronic pancreatitis and later on celiac disease was confirmed. Despite a completed work-up search for another diagnosis of chronic pancreatitis, the result was negative. Fecal elastase 1-determination in celiac may be useful in detecting and curing exocrine pancreatic insufficiency, especially in patients with a new diagnosis of celiac disease or in those with the refractory diarrhea that was described in this review [17]. However, cases of celiac disease with extra-intestinal symptoms are always challenging to diagnose without high clinical indices. Historically there are few reported cases of pancreatic disorders in celiac disease, and one of the reported cases, the case of a young woman with chronic calcific pancreatitis in whom non-response to treatment was due to celiac disease, is described [18]. Later, many reports followed, describing similar cases with variety of pancreatic diseases [19,20-24] Patel RS et al described in a retrospective study of 169 patients with sphincter of odd dysfunction and recurrent pancreatitis that 12 of those patients were diagnosed with Celiac disease (7.1%). This study suggested that Celiac disease should be considered in the etiology of papillary stenosis or idiopathic recurrent pancreatitis [25]. One theory behind the association of pancreatitis in celiac patient is the presence of pancreatitis-associated protein (PAP), which leads the authors to observe that the active phase of the disease was accompanied by an increased serum concentration of PAP [26]. The disease is not restricted to or specific to certain age group, and a retrospective study of 7 patients showed that the celiac disease is under-diagnosed in elderly patients, and that it can be presented with a wide spectrum clinical picture including a common gastro-intestinal and extra-intestinal manifestations [27]. Health care providers should understand all clinical practice in the treatment of celiac disease, because this is a common condition with diverse manifestations that can be effectively diagnosed and easily treated for the prevention of both acute and long-term complications. Patients should follow a strictly gluten-free diet for life to prevent reoccurrence [28]. The extra-intestinal symptoms of associated illnesses may appear both at the time of diagnosis and throughout the evolution of the disease, and an adequate adherence to a GFD may slow down their evolution, especially if implemented during an early stage [29]. Overall, autoimmune diseases occur more frequently in those with celiac disease than in the general population. To conclude, the present case brings to the fore the need for full systemic examination of the symptoms of celiac disease and the effective management of the celiac to treat the extra-intestinal symptoms of the disease.

 

Figure 1: ERCP showed a normal biliary tree

 

 

Figure 2: MRI: pancreas showed a feature of chronic pancreatitis

 

 

Figure 3: EUS images showed a feature of severe chronic pancreatitis

 

 

Figure 4: Upper Endoscopy showed a flat scalloping duodenal mucosa


  1. Jiang LL1, Zhang BL, Liu YS (2009) Is adult celiac disease really uncommon in Chinese? J Zhejiang Univ Sci B 10: 168-171.
  2. Collin P1, Huhtala H, Virta L, Kekkonen L, Reunala T (2007) Diagnosis of celiac disease in clinical practice: physician’s alertness to the condition essential. J Clin Gastroenterol 41: 152-156.
  3. Halfdanarson TR1, Litzow MR, Murray JA (2007) Hematologic manifestations of celiac disease. Blood 109: 412-421.
  4. Volta U1, Caio G, Stanghellini V, De Giorgio R (2014) The changing clinical profile of celiac disease: a 15-year experience (1998-2012) in an Italian referral center. BMC Gastroenterol 14: 194.
  5. Aziz I1, Hadjivassiliou M2 (2014) Coeliac disease: noncoeliac gluten sensitivity–food for thought. Nat Rev Gastroenterol Hepatol 11: 398-399.
  6. Addolorato G1, Leggio L, D’Angelo C, Mirijello A, Ferrulli A, et al. (2008) Affective and psychiatric disorders in celiac disease. Dig Dis 26: 140-148.
  7. Ghozzi M, Sakly W, Mankaï A, Bouajina E, Bahri F et al (2014). Screening for celiac disease, by endomysial antibodies, in patients withunexplained articular manifestations.Rheumatol Int. 34:637-42.
  8. Piccolboni P, Ragone E, Inzirillo A, Utili R (2013) Primary sclerosing cholangitis in patient with celiac disease complicated by cholecystic empyema and acute pancreatitis. G Chir 34: 267-270.
  9. Kummen M1, Schrumpf E, Boberg KM (2013) Liver abnormalities in bowel diseases. Best Pract Res Clin Gastroenterol 27: 531-542.
  10. Pastore L1, Carroccio A, Compilato D, Panzarella V, Serpico R, et al. (2008) Oral manifestations of celiac disease. J Clin Gastroenterol 42: 224-232.
  11. Sadr-Azodi O1, Sanders DS, Murray JA, Ludvigsson JF (2012) Patients with celiac disease have an increased risk for pancreatitis. Clin Gastroenterol Hepatol 10: 1136-1142.
  12. Ludvigsson JF1, Montgomery SM, Ekbom A (2007) Risk of pancreatitis in 14,000 individuals with celiac disease. Clin Gastroenterol Hepatol 5: 1347-1353.
  13. Masoodi I1, Wani H, Alsayari K, Sulaiman T, Hassan NS, et al. (2011) Celiac disease and autoimmune pancreatitis: an uncommon association. A case report. Eur J Gastroenterol Hepatol 23: 1270-1272.
  14. Basha J1, Appasani S, Vaiphei K, Singh K, Kochhar R (2012) Celiac disease presenting as recurrent pancreatitis and pseudocyst. JOP 13: 533-535.
  15. Halabi IM1 (2010) Coeliac disease presenting as acute pancreatitis in a 3-year-old. Ann Trop Paediatr 30: 255-257.
  16. Bultron G1, Latif U, Park A, Phatak U, Pashankar D, et al. (2009) Acute pancreatitis in a child with celiac disease. J Pediatr Gastroenterol Nutr 49: 137-138.
  17. Pezzilli R1 (2014) Exocrine pancreas involvement in celiac disease: a review. Recent Pat Inflamm Allergy Drug Discov 8: 167-172.
  18. Sood A1, Midha V, Sood N, Bansal M, Kaur M, et al. (2007) Coexistence of chronic calcific pancreatitis and celiac disease. Indian J Gastroenterol 26: 41-42.
  19. Rana SS, Bhasin DK, Sinha SK, Singh K (2007) Coexistence of chronic calcific pancreatitis and celiac disease. Indian J Gastroenterol 26: 150.
  20. Arya S1, Rana SS, Sinha SK, Nagi B, Bhasin DK (2006) Celiac disease and chronic calcific pancreatitis with pancreas divisum. Gastrointest Endosc 63: 1080-1081.
  21. Gregar I, Kojecký Z, Lojda Z, Matlocha Z (1987) Enteropeptidase (EC 3.4.21.9) in coeliac disease and exocrine pancreatic insufficiency. Acta Univ Palacki Olomuc Fac Med 116: 247-252.
  22. Pitchumoni CS, Thomas E, Balthazar E, Sherling B (1977) Chronic calcific pancreatitis in association with celiac disease. Am J Gastroenterol 68: 358-361.
  23. Thomson A (2005) Celiac disease as a cause of pancreatitis. Gastroenterology 129: 1137.
  24. Hillman L (2005) Coeliac disease and pancreatitis. Intern Med J 35: 374-375.
  25. Patel RS1, Johlin FC Jr, Murray JA (1999) Celiac disease and recurrent pancreatitis. Gastrointest Endosc 50: 823-827.
  26. Carroccio A, Iovanna JL, Iacono G, Li Pani M, Montalto G et al. (1997) Barthellémy-Bialas S, Dagorn JC. Pancreatitis-associated protein in patientswith celiac disease: serum levels and immunocytochemical localization in smallintestine. Digestion. 58:98 103.
  27. Lurie Y1, Landau DA, Pfeffer J, Oren R (2008) Celiac disease diagnosed in the elderly. J Clin Gastroenterol 42: 59-61.
  28. Schuppan D1, Zimmer KP (2013) The diagnosis and treatment of celiac disease. Dtsch Arztebl Int 110: 835-846.
  29. Lauret E1, Rodrigo L (2013) Celiac disease and autoimmune-associated conditions. Biomed Res Int 2013: 127589.

© by the Authors & Gavin Publishers. This is an Open Access Journal Article Published Under Attribution-Share Alike CC BY-SA: Creative Commons Attribution-Share Alike 4.0 International License. Read More About Open Access Policy.

Update cookies preferences